USANA Health Sciences

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$213,670
$235,848
$249,539
$213,613
Gross Profit
164,855
185,664
197,094
175,060
EBITDA
11,410
28,680
27,395
16,442
EBIT
1,843
19,076
17,150
10,558
Net Income
-6,522
9,655
9,402
4,484
Net Change In Cash
213,670
235,848
249,539
213,613
Free Cash Flow
-5,159
7,191
12,679
3,983
Cash
145,349
151,338
179,613
181,768
Basic Shares
18,293
18,536
19,085
19,104

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$854,503
$921,010
$998,601
$1,186,464
Gross Profit
693,291
744,317
804,711
968,566
EBITDA
98,861
123,110
129,024
192,385
EBIT
76,632
102,715
107,614
170,192
Net Income
42,030
63,788
69,350
116,505
Net Change In Cash
854,503
921,010
998,601
1,186,464
Cost of Revenue
-74,372
Free Cash Flow
50,919
56,147
93,502
108,464
Cash
181,768
330,420
288,420
239,832
Basic Shares
19,162
19,345
19,310
20,343

Earnings Calls

QuarterEPS
2025-09-30
-$0.15
2025-06-30
$0.74
2025-03-31
$0.73
2024-12-31
$0.64